OTLK · Healthcare · $117M
Pre-market $0.63+0.02%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Among 326 Biotechnology peers
“3주 전 미국 식품의약국 승인을 받으며 매출이 거의 없던 개발 단계에서 상업화 단계로 전환했어요.”
In the company's words · 2026 3분기 earnings call